trial
as of 2026-07-01Efficacy of tACS for Treatment of Auditory Hallucinations in Refractory Schizophrenia
NCTId NCT05282329
at a glance
— · Completed
Enrollment 50 (actual)
Sponsored by Tianjin Anding Hospital
Primary completion 2022-08-31
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
50 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2020-09-01
Primary completion
2022-08-31
Eligibility
ALL · 18 Years · 70 Years
Interventions & indications
Sponsors
Tianjin Anding HospitalLead Sponsor
Sites
1 total
Tianjin, China
Facts & assertions
4 sourced
Enrollment
50
Phase
NA
Primary Completion Date
2022-08-31
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
company
indication
indication
indication